Description
Used in the treatment of:
- Non-Hodgkin’s Lymphoma (NHL)
- Chronic Lymphocytic Leukemia (CLL)
- Rheumatoid arthritis
Rituximab is a monoclonal antibody that targets the CD20 antigen on B-lymphocytes, leading to cell lysis and depletion of abnormal B-cells.



